Ziopharm Oncology Appoints Kevin Buchi to its Board of Directors

NEXT STORY
In vitro Diagnostics Market is Forecast to Rise at 4.5% CAGR and Reach USD 87.11 Billion by 2026; Launch of Altostar Molecular Diagnostics Workflow by Altona Diagnostics Gmbh Will Support Growth, says Fortune Business Insights
PREV STORY
Neuronetics Unveils New Depression Data at Clinical TMS Society’s Virtual Events
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Basilea beginnt Phase-1/2-Studie FIDES-03 mit Derazantinib bei Patienten mit Magenkrebs

author_avatar
NASDAQ Market News

India and Neighboring Countries PoC Molecular Diagnostics Market to Touch USD 6432.57 Million by 2026; Market Reach to Expand with Rising Need to Curb Transmission of the COVID-19

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Announces In Vivo Study to Evaluate the Effects of CPI-613® (Devimistat) in Combination with Azacitidine and Venetoclax on Acute Myeloid Leukemia Models

author_avatar
NASDAQ Market News